Key facts
- Reimagine Care’s last known valuation is $7.0M (Nov 2025).
- It has raised $27.4M across 2 recorded rounds; the latest was Seed Round ($2.4M) in Nov 2025.
- Notable investors include First Trust Capital Partners, Martin Ventures, McKesson Ventures, CancerX (USA), City of Hope — 12 tracked in total.
- Reimagine Care has filed 3 Form Ds with the SEC since 2021, most recently Nov 2025 ($2.4M sold to 7 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 12 names
- ·Watchlist + deal alerts for Reimagine Care
Funding rounds
2 roundsAbout Reimagine Care
Provider of patient-centric cancer care services intended to support community oncologists and healthcare systems. The company's services provide scalable and effective delivery of low-cost cancer care across multiple sites, enabling patients to receive cancer treatment and supportive care at home.
- Sector
- Healthcare
- HQ
- Nashville, TN, United States
- Founded
- 2020
- Employees
- 36
- Website
- reimaginecare.com/
- Ownership
- Privately Held (backing)
Reimagine Care doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Reimagine Care shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Reimagine Care in its N-PORT filings yet. We sweep new filings monthly.